Abstract:BACKGROUND: Liver transplantation is an effective treatment for end-stage liver disease, but a huge gap remains between the number of people who need a liver transplant and the number of organs available. In order to maximize donor organ access for adult and pediatric recipients, novel surgical and liver replacement procedures have evolved. Newer surgical techniques include split cadaveric liver transplantation and living donor liver transplantation (LDLT). With marginal and abnormal donor livers, despite tremendous advances in surgical technology, individual surgical procedure can not be completely brought into play unless effective measurements and basal studies are undertaken.DATA SOURCES: A literature search of MEDLINE and the Web of Science database using "liver transplantation" and "expanding donor pool" was conducted and research articles were reviewed.RESULTS: Therapies directed toward scavenging O2-, inhibiting nicotinamide adenine dinucleotide phosphate oxidase, and/or immuno-neutralizing tumor necrosis factor-alpha may prove useful in limiting the liver injury induced by surgical procedures such as split liver transplantation or LDLT. Improved donor organ perfusion and preservation methods, modulation of inflammatory cytokines, energy status enhancement, microcirculation amelioration, and antioxidant usage can improve non-heart beating donor liver transplantation. Effective measures have been taken to improve the local conditions of donor cells with steatosis, including usage of fat-derived hormone and inflammatory mediators, ischemic preconditioning, depletion of Kupffer cells, and cytokine antibody and gene therapy. Double-filtration plasmapheresis can effectively reduce HCV viremia and prevent HCV recurrence in patient with high HCV RNA levels after LDLT.CONCLUSIONS: Shortage of grafts and poor function of marginal and abnormal donor grafts put many patients at risk of death in waiting for liver transplantation. Advances in surgical technology, combined with improvement and breakthroughs in basic studies hold a promise in expanding the liver donor pool.

Integrated transcriptomics and histopathology approach identifies a subset of rejected donor livers with potential suitability for transplantation

Extended criteria donor reconditioning and functional improvement in the viewshed of machine perfusion plus

Changing landscape of liver transplant in the United States- time for a new innovative way to define and utilize the "non-standard liver allograft"-a proposal

Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors.

Decoding the hallmarks of allograft dysfunction with a comprehensive pan-organ transcriptomic atlas

Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future

Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis

A Case Report on Successful Liver Transplantation from a Donor with Polycystic Liver

Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era

Challenges and Opportunities of Liver Xenotransplantation

Key genes and immune pathways in T-cell mediated rejection post-liver transplantation identified via integrated RNA-seq and machine learning

Dissecting the Immune Discrepancies in Mouse Liver Allograft Tolerance and Heart/kidney Allograft Rejection.

Decoding Single-cell Landscape and Intercellular Crosstalk in the Transplanted Liver

Role of Basic Studies in Expanding the Donor Pool for Liver Transplantation

Human hepatocyte transplantation for liver disease: current status and future perspectives

Pre-operative assessment of living liver donors' liver anatomy and volumes

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation

Liver Transplantation Using the Otherwise-Discarded Partial Liver Resection Graft with Hepatic Benign Tumor

Bioenergetic and Cytokine Profiling May Help to Rescue More DCD Livers for Transplantation

[Multimodal Approach to Clinical Liver Transplantation].

Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria